Searched for
MANKIND PHARMA SHARE PRICE
Bitcoin trades near $79,000 as Fed rate uncertainty, selling pressure weigh on crypto marketsBitcoin slipped near $79,000 as investors awaited the Federal Reserve’s policy decision. ETF outflows, macroeconomic uncertainty and sellin...- Forget short-term pressure; in the long term, the right business is what pays: 5 mid-cap stocks with an upside potential of up to 36%We have said this before, and we say it again: No one can predict when the market will bottom out. You can see the bottom only in hindsight...
- Worried about long-term returns? No equity mutual fund lost money on 5- and 7-year SIPsNo equity mutual fund delivered negative SIP returns over five- and seven-year periods, an ETMutualFunds analysis found. Quant Small Cap Fu...
- D-Street in gloomy mood, but Kotak sees 3 triggers for rebounds and adds 5 midcap stocks to portfolioDalal Street faces significant market challenges, leading Kotak Institutional Equities to spotlight selective stock value. With large-cap s...
- Diwali stock picks! Axis picks Eternal, Hindalco, 7 other stocks with upside potential of up to 20%. See full listAxis Direct has identified nine stocks for Diwali Samvat 2082, with projected upside of 15% to 20%. Its picks span banking, healthcare, hos...
- Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 croreMankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, s...
- Mankind Pharma among 5 F&O stocks with a sharp rise in futures open interestFive NSE F&O stocks recorded a rise of over 7% in futures open interest on October 26, with Radico Khaitan leading at 16.05%, followed by M...
- Mankind Pharma Q2 profit rises 38% to Rs 716 croreMankind Pharma has announced a profit increase of 37.7% to ₹716 crore during the September quarter. Revenue from operations rose to ₹4,337....
- Mankind Pharma shares key business developments from Q2 & H1 of FY27The company outperformed the market by 1.1 times in both chronic and acute therapies. Cardiac and anti-diabetes brands registered growth of...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Coforge slips 3% even as Jefferies, Nomura, others raise targets after Q2 earnings. Why are they bullish?Coforge shares fell despite strong Q2 results and brokerages raising target prices. Net profit surged 56.5% year-on-year to Rs 588.1 crore,...
- Top Nifty50 stocks analysts suggest buying in this volatile weekStock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...
- Bharat Electronics among 4 Sensex stocks to hit 52-week lows; shares fall up to 9% in a monthFour Sensex stocks, including Bharat Electronics, NTPC, Power Grid Corporation and Hindustan Unilever, touched fresh 52-week lows on Friday...
- Two Trades for Today: A top pharma company for a 6.3% upmove, a large-cap hospitality stock for a gain of almost 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Every bad cycle ends the same way; problems find their own solutions: 5 large-cap stocks with upside potential of up to 27%What should you focus on when headwinds blow? Not the share price, and not the morning's news. It should be the business and the quality of...
- Sky Gold and Diamonds among 5 stocks that hit 52-week highs and rallied up to 45% in a monthDespite the Sensex falling 143 points on Wednesday, five BSE 1000 stocks hit fresh 52-week highs. PC Jeweller led monthly gains at 45%, fol...
- Sun Pharma to raise Rs 10,000 crore to part-finance Organon dealSun Pharmaceutical Industries plans to raise ₹10,000 crore through two tranches of rupee-denominated bonds. The funds will help refinance b...
- CPHI Milan: Beyond generics, how Indian pharma is rewriting its global playbookAt CPHI Milan, Indian pharma players are looking beyond traditional exports, using partnerships, licensing, CDMO, and differentiated produc...
- When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...
Load More
